Your guide to fall 2026 vaccines
Respiratory vaccines—for flu, RSV, and Covid-19—will be available at no cost this fall.
Fall 2026 brings a host of vaccines to keep you protected: seasonal flu, respiratory syncytial virus (RSV), and Covid-19. These vaccines can be obtained free of charge, regardless of the ongoing lack of a federal campaign. While each vaccine has its own set of nuances, the most crucial takeaway is to receive whichever vaccine aligns with your needs for maximum protection.
Starting with seasonal influenza, the vaccine this year covers three strains, all updated for the 2026-2027 season. The three vaccines come from five manufacturers, and while the strains may not always align perfectly, the vaccines collectively reduce the risk of needing to visit a doctor by 30% to 60%. For young children, the nasal spray flu vaccine, FluMist, may offer slightly better protection.
Older adults might find the adjuvanted flu vaccine (Fluad) more effective, and a newer mRNA flu vaccine, mFlusvia, is available for those 50 and older, albeit with a higher likelihood of side effects.
When it comes to RSV, there are three options: vaccines from GSK, Pfizer, and Moderna. The first two use traditional protein-based technology, while Moderna's vaccine is an mRNA-based one. GSK and Pfizer vaccines have a low risk of Guillain-Barre syndrome, similar to flu vaccines. Moderna's vaccine does not carry this risk but provides less lasting protection. RSV vaccines are recommended for those over 50 with high-risk conditions and everyone over 75, ideally before the onset of the season for the best protection.
Written by urgent.news from Your Local Epidemiologist's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
